Translational Research

Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC; Australian Cancer Study Group; Australian Ovarian Cancer Study Group. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer. 2008 Nov;44(16):2477-84. Epub 2008 Aug 15.

Olsen CM, Nagle CM, Whiteman DC, Purdie DM, Green AC, Webb PM; Australian Cancer Study (Ovarian Cancer) and Australian Ovarian Cancer Study Group. Body size and risk of epithelial ovarian and related cancers: a population-based case-control study. Int J Cancer. 2008 Jul 15;123(2):450-6.

Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, Pharoah PD, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Terry KL, Cramer DW, Tworoger SS, Hankinson SE, Berchuck A, Moorman PG, Schildkraut JM, Cunningham JM, Liebow M, Kjaer SK, Hogdall E, Hogdall C, Blaakaer J, Ness RB, Moysich KB, Edwards RP, Carney ME, Lurie G, Goodman MT, Wang-Gohrke S, Kropp S, Chang-Claude J; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer), Webb PM, Chen X, Beesley J, Chenevix-Trench G, Goode EL; Ovarian Cancer Association Consortium. Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer. 2008 Jul 15;123(2):380-8.

Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, Doherty JA, Rossing MA, Whittemore AS, McGuire V, DiCioccio RA, Goodman MT, Lurie G, Carney ME, Wilkens LR, Ness RB, Moysich KB, Edwards R, Jennison E, Kjaer SK, Hogdall E, Hogdall CK, Goode EL, Sellers TA, Vierkant RA, Cunningham JM, Schildkraut JM, Berchuck A, Moorman PG, Iversen ES, Cramer DW, Terry KL, Vitonis AF, Titus-Ernstoff L, Song H, Pharoah PD, Spurdle AB, Anton-Culver H, Ziogas A, Brewster W, Galitovskiy V, Chenevix-Trench G; Australian Cancer Study; Australian Ovarian Cancer Study Group. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer. 2009 Jan 27;100(2):412-20. Epub 2009 Jan 6. Erratum in: Br J Cancer. 2009 Nov 17;101(10):1805. Cunningham, J C [corrected to Cunningham, J M].

Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. Epub 2008 Oct 28.

Schmid BC, Buluwela L, Liu QY, Fasching B, Tong D, Stimpfl M, Obermair A, Leodolter S, Zeillinger R: Expression of MUC1 splice variants correlates with invasive growth of breast cancer cell lines. Breast Cancer Res Treat 2002;76:211-219.

Bachtiary B, Obermair A, Dreier B, Birner P, Breitenecker G, Knocke TH, Selzer E, Potter R: Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer 2002; 102: 237-243.

Kohlberger, Muller-Klingspor, Heinzl H, Obermair A, Breitenecker G, Leodolter S: Prognostic value of laminin-5 in serous adenocarcinomas of the ovary. Anticancer Res 2002;22:3541-4.

Bachtiary B, Selzer E, Knocke TH, Poetter R, Obermair A: Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival. Cancer Lett. 2002;179:197-203.

Stimpfl M, Tong D, Fasching B, Schuster E, Obermair A, Leodolter S, Zeillinger R: Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Clin Cancer Res. 2002;8:2253-2259

Obermair A, Schmid BC, Packer LM, Leodolter S, Birner P, Ward BG, Crandon AJ, McGuckin MA, Zeillinger R: Expression of MUC1 splice variants in benign and malignant ovarian tumours. Int J Cancer 2002; 100: 166-171.

Csapo B, Szeles J, Helbich TH, Klarhoefer M, Balassy C, Pammer J, Obermair A: Histopathologic correlation of high resolution magnetic resonance imaging of human cervical tissue samples at 3 tesla: validation of technique. Invest Radiol 2002; 37: 381-385.

Tong D, Fabjani G, Heinze G, Obermair A, Leodolter S, Zeillinger R: Ananlysis Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients. Int J Cancer. 2001; 95: 394-397.

Obermair A, Schmid BC, Stimpfl M, Fasching B, Preyer O, Leodolter S, Crandon AJ, Zeillinger R: Novel MUC1 splice variants are expressed in cervical carcinoma. Gynecol Oncol 2001; 83: 343-347.

Schindl M, Oberhuber G, Pichlbauer EG, Obermair A, Birner P, Kelley MR: DNA Repair-Redox Enzyme Apurinic Endonuclease in Cervical Cancer: Evaluation of Redox-Control of HIF-1alpha and Prognostic Significance. Int J Oncol, 2001; 19: 799-802.

Muller-Klingspor V, Hefler L, Obermair A, Kaider A, Breitenecker S, Kohlberger P: Prognostic value of beta1-integrin (=CD29) in serous adeneocarcinoma of the ovary. Anticancer Res 2001; 21: 2185-2188.

Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P: Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Research 2001; 61:5703-5706.

Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G: Expression of hypoxia-inducivle factor 1 alpha in epithelial ovarian tumours: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 2001; 7: 1661-1668.

Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G: Overexpression of hypoxia-inducible factor 1 alpha is a marker for an unfavourable prognosis in early-stage cervical cancer. Cancer Res 2000; 60: 4693-4696.

Schreiber S, Ackermann J, Obermair A, Kaufmann H, Urbauer E, Aletaha K, Gisslinger H, Chott A, Huber H, Drach J: Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow neovascularization. Br J Haematol. 2000; 110: 605-609.

Obermair A, Schmid BC, Leodolter S, Zeillinger R: Messenger RNA expression of MUC1 splice variants in epithelial ovarian cancer. Austral Asian J Cancer 2000; 1: 69-75.

Stimpfl M, Schmid BC, Obermair A, Tong D, Schiebel I, Gitsch G, Leodolter S, Zeillinger R: Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood. Oncol Res 2000; 11: 367-373..

Stimpfl M, Schmid BC, Schiebel I, Tong D, Gitsch G, Leodolter S, Obermair A, Zeillinger R: Expression of mucins and cytokeratins in ovarian cancer cell lines: possible markers to detect disseminated ovarian cancer cells. Cancer Lett 1999; 145: 133-141.

Obermair A, Obruca A, Phl M, Kaider A, Vales A, Wojta J, Leodolter S, Feichtinger W: Vascular Endothelial Growth factor and its receptors in male fertility. Fertil Steril 1999; 72: 269-275.

Bancher-Todesca D, Gitsch G, Williams KE, Kohlberger P, Neunteufel W, Obermair A, Heinze G, Breitenecker G, Hacker NF: p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma. Gynecol Oncol 1998; 71: 59-63.

Reisenberger K, Egarter C, Schiebel I, Obermair A, Kiss H, Lehner R: In vitro cytokine and prostaglandin production by amnion cells in the presence of bacteria. Am J Obstet Gynecol 1997; 176: 981-984.